Shah N - Search Results

1

Nothing but NET: a review of norepinephrine transporter expression and efficacy of 131I-mIBG therapy.

Streby KA, Shah N, Ranalli MA, Kunkler A, Cripe TP. Streby KA, et al. Among authors: shah n. Pediatr Blood Cancer. 2015 Jan;62(1):5-11. doi: 10.1002/pbc.25200. Epub 2014 Aug 30. Pediatr Blood Cancer. 2015. PMID: 25175627 Free PMC article. Review.

2

Romiplostim for therapy-related thrombocytopenia in pediatric malignancies.

Jacobson AE, Shah N, Setty BA. Jacobson AE, et al. Among authors: shah n. Pediatr Blood Cancer. 2017 Aug;64(8). doi: 10.1002/pbc.26473. Epub 2017 Feb 2. Pediatr Blood Cancer. 2017. PMID: 28150377

3

Clinical efficacy of cabozantinib in two pediatric patients with recurrent renal cell carcinoma.

Wedekind MF, Ranalli M, Shah N. Wedekind MF, et al. Among authors: shah n. Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26586. Epub 2017 Apr 18. Pediatr Blood Cancer. 2017. PMID: 28417541

4

Cabozantinib for relapsed neuroblastoma: Single institution case series.

Perisa MP, Storey M, Streby KA, Ranalli MA, Skeens M, Shah N. Perisa MP, et al. Among authors: shah n. Pediatr Blood Cancer. 2020 Jul;67(7):e28317. doi: 10.1002/pbc.28317. Epub 2020 Apr 28. Pediatr Blood Cancer. 2020. PMID: 32343886 Clinical Trial.

5

Caregiver Perspectives on Patient Participation in Biological Pediatric Cancer Research.

Kendel NE, Belsky JA, Stanek JR, Streby KA, Shah N. Kendel NE, et al. Among authors: shah n. Children (Basel). 2022 Jun 16;9(6):901. doi: 10.3390/children9060901. Children (Basel). 2022. PMID: 35740838 Free PMC article.

6

Utilizing a Quality Improvement Strategy to Increase Faculty Engagement With Resident Learning Goals.

Reed S, Treinen C, Shah N, Ranalli M, Olshefski R. Reed S, et al. Among authors: shah n. Acad Pediatr. 2023 Jan-Feb;23(1):201-208. doi: 10.1016/j.acap.2022.09.007. Epub 2022 Sep 16. Acad Pediatr. 2023. PMID: 36122828 Review.

7

Factors affecting COVID-19 vaccine hesitancy in parents of children with cancer.

Skeens MA, Hill K, Olsavsky A, Buff K, Stevens J, Akard TF, Shah N, Gerhardt CA. Skeens MA, et al. Among authors: shah n. Pediatr Blood Cancer. 2022 Jun;69(6):e29707. doi: 10.1002/pbc.29707. Epub 2022 Apr 5. Pediatr Blood Cancer. 2022. PMID: 35384278 Free PMC article.

8

Successful use of tacrolimus for treatment-refractory neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome: A case series.

Delap S, Shah N, Kuns O, Franklin B, Skeens MA. Delap S, et al. Among authors: shah n. Pediatr Blood Cancer. 2024 Apr;71(4):e30903. doi: 10.1002/pbc.30903. Epub 2024 Feb 6. Pediatr Blood Cancer. 2024. PMID: 38321586

9

Dodging the bullet: therapeutic resistance mechanisms in pediatric cancers.

Shah N. Shah N. Cancer Drug Resist. 2019 Sep 19;2(3):428-446. doi: 10.20517/cdr.2019.20. eCollection 2019. Cancer Drug Resist. 2019. PMID: 35582583 Free PMC article. Review.

10

CHEK2 Alterations in Pediatric Malignancy: A Single-Institution Experience.

Abdelghani E, Schieffer KM, Cottrell CE, Audino A, Zajo K, Shah N. Abdelghani E, et al. Among authors: shah n. Cancers (Basel). 2023 Mar 8;15(6):1649. doi: 10.3390/cancers15061649. Cancers (Basel). 2023. PMID: 36980535 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,042 results

Search Page

Filters